|
ENDOD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.361200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.242200E-03 |
| Normal-vs-Stage2 |
7.418800E-01 |
| Normal-vs-Stage3 |
2.167000E-01 |
| Normal-vs-Stage4 |
5.501200E-03 |
| Stage1-vs-Stage2 |
2.120400E-02 |
| Stage1-vs-Stage3 |
4.049000E-04 |
| Stage1-vs-Stage4 |
1.23530000006866E-07 |
| Stage2-vs-Stage3 |
5.554800E-01 |
| Stage2-vs-Stage4 |
7.142000E-02 |
| Stage3-vs-Stage4 |
1.901760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.413200E-01 |
| Normal-vs-AfricanAmerican |
7.238400E-01 |
| Normal-vs-Asian |
7.465800E-01 |
| Caucasian-vs-AfricanAmerican |
8.974400E-01 |
| Caucasian-vs-Asian |
7.521800E-01 |
| AfricanAmerican-vs-Asian |
8.191200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.894600E-01 |
| Normal-vs-Female |
2.961500E-02 |
| Male-vs-Female |
2.004300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.787400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.055400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.668400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.160600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.385000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.429000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.555780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.541200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.114200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.393400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.626300E-02 |
| Normal-vs-Grade 2 |
3.526200E-02 |
| Normal-vs-Grade 3 |
7.966400E-01 |
| Normal-vs-Grade 4 |
1.371410E-04 |
| Grade 1-vs-Grade 2 |
2.051400E-01 |
| Grade 1-vs-Grade 3 |
8.690000E-02 |
| Grade 1-vs-Grade 4 |
1.152260E-02 |
| Grade 2-vs-Grade 3 |
2.205800E-02 |
| Grade 2-vs-Grade 4 |
1.30780000162645E-08 |
| Grade 3-vs-Grade 4 |
3.957700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.722000E-03 |
| Normal-vs-ccB subtype |
8.254000E-01 |
| ccA subtype-vs-ccB subtype |
7.404800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.940800E-01 |
| Normal-vs-N1 |
9.053400E-01 |
| N0-vs-N1 |
8.549600E-01 |
|
|
